More MS news articles for Oct 2001

Cannabis change lifts drugs group

24 October 2001

SHARES in cannabis extract developer GW Pharmaceuticals rose 15% to 109p, a gain of 14p, after Tuesday's announcement by Home Secretary David Blunkett that he intends to reclassify the drug and allow its use as a painkiller.

GW provides extracts from cannabis that give relief to patients suffering from multiple sclerosis, cancer, arthritis and other serious medical conditions. Its executive chairman Dr Geoffrey Guy said: 'We are delighted that the Home Secretary continues to recognise the potential importance of these medicines for patients.'

GW is in Phase III clinical trials of drugs based on cannabis extract and is on course to make its first submission to the Medicines Controls Agency in 2003. Doctors will be able to prescribe its drugs to patients if the agency approves them and Blunkett legalises such a move. GW's products avoid the harmful effects of smoking the drug.

© Associated Newspapers Ltd.